SpeakersView Speaker Bios
Professor Carlos Camargo BA MD MPH DrPH
Professor of Emergency Medicine, Medicine and Epidemiology, Harvard University, and the Conn Chair in Emergency Medicine, Massachusetts General Hospital, Boston
Professor Carlos Camargo received his BA from Stanford, MD from UCSF, and MPH from UC Berkeley. In 1990, he moved to Boston for his residency at Massachusetts General Hospital then did fellowship training at Brigham & Women's Hospital, Boston. In 1996, he received his DrPH from Harvard School of Public Health.
In 1996, Professor Camargo founded the Emergency Medicine Network (EMNet), an international research collaboration with almost 250 hospitals, and a mission to advance public health objectives through diverse projects in emergency care. Two major areas of EMNet research are: the MARC program, which focuses on respiratory/allergy emergencies, and health services research in emergency care.
Professor Camargo has also worked for more than 20 years on the role of nutrition in respiratory/allergy disorders, both in cohort studies (including the Nurses' Health Studies) and in large randomized controlled trials (including health effects of vitamin D). He is past president of the American College of Epidemiology, and has worked on several US guidelines including those on diet, asthma, and food allergy. He is an author of more than 900 publications, with over 55,000 citations.
Professor David Jayne FMedSci
Professor of Clinical Autoimmunity, School of Clinical Medicine, University of Cambridge, UK
Professor David Jayne's research group conducts clinical trials and biomarker studies in vasculitis and lupus, including clinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease. He is also involved in the co-ordination of international clinical research vasculitis network (EUVAS) and multi-centre randomised controlled trials.
The development of clinical trial methodology, management guidelines and implementation of best clinical practice is Professor Jayne's main interest, as well as the support of genetic, gene expression and biomarker studies. He is the Director of the Vasculitis and Lupus Clinic and President of the European Vasculitis Society.
Associate Professor David Fleischer, MD
Associate Section Head, Director, Allergy and Immunology Center, School of Medicine, Children's Hospital Colorado, University of Colorado, USA
A/Prof Fleischer's primary clinical interest is food allergy - from the time point of accurate diagnosis, usually at a young age, and the multidisciplinary care of the patient to include psychosocial and dietitian support, through the natural history and hopefully resolution of the allergy. He also believes in helping the patient and the family navigate the management of food allergy from the young age, through important transitions to self-care of school-age children, and then independent living with food allergy as adolescents and adults.
A/Prof Fleischer's research also focuses on food allergy, in particular peanut and tree nut allergies. He is interested in why certain patients with food allergies outgrow them more readily and sooner than others. He is an investigator in treatments for food allergy, including oral, sublingual, and epicutaneous immunotherapies.
Professor Marc Riedl MD MS
Professor of Medicine and Clinical Director, US HAE Angioedema Center, and Training Program Director for Allergy-Immunology, University of California, San Diego
Professor Marc Riedl received his medical degree from the University of Chicago Pritzker School of Medicine, completed Internal Medicine residency at Barnes-Jewish Hospital of Washington University in St. Louis, and a Clinical Immunology and Allergy fellowship at UCLA. He received a Master of Science degree in Clinical Research from UCLA and holds board certifications in Allergy-Immunology and Clinical Pharmacology.
Professor Riedl serves on numerous editorial boards and scientific committees, as well as appointed expert panels for the Food and Drug Administration (FDA) and the National Institutes for Health (NIH). He also directs an active clinical research program at UCSD focused on angioedema and immunodeficiency conditions.
Professor Jonathan Spergel MD PhD
Professor of Pediatrics, University of Pennsylvania School of Medicine and Chief of the Allergy Section, Children's Hospital of Philadelphia. Stuart Starr Endowed Chair of Pediatrics and Director of Center for Eosinophilic Diseases.
Professor Jonathan Spergel received his medical and graduate education at the Mount Sinai School of Medicine and completed his pediatric residency at Yale-New Haven Hospital. His clinical and post-graduate research training in Allergy and Immunology were completed at Children's Hospital, Harvard Medical School, Boston, MA.
Professor Spergel is Board Certified in Pediatrics and Allergy and Immunology. He is a fellow of the American Academy of Allergy Asthma and Immunology (AAAAI), American College of Allergy, Asthma and Immunology (ACAAI), American Association of Pediatrics, and Philadelphia College of Physicians. He has served and chaired national and international committees on food allergy, atopic dermatitis and eosinophilic esophagitis.
Professor Spergel is the principal investigator for multiple studies in the fields of atopic dermatitis, eosinophilic esophagitis and food allergies. He has published over 160 articles as well as speaking nationally and internationally in these fields. His current research focuses on both clinical (desensitization and tolerance) and translational research in Eosinophilic Esophagitis and Food Allergy including fibrosis, regulatory T cells, microbiome and genetic pathways. His research is funded by FARE, DBV Technology, NIH, PCORI and EATS foundation.
Dr Gulbu Uzel MD
Fellow National Institutes of Health, USA and private Clinical practice in Lansdowne, Virginia, USA, specializing in rheumatology and clinical and laboratory immunology.
Dr Gulbu Uzel studied medicine at the Faculty of Medicine Ankara University and completed her pediatric residency at Sinai Hospital, Baltimore. She joined the Allergy and Immunology Fellowship Program at the National Institutes of Health (NIH). During her fellowship training, she carried out basic and clinical immunology research at one of the most reputable immunology laboratories studying host defense defects. Dr Uzel led clinical trials including Evaluation of the Immune Response to Vaccines in Primary Immune Disorders and the Genetic Analysis of Immune Disorders. She continued her postdoctoral studies at the Human Genome Institute and became part of the lab that pioneered newborn screening of Severe Combined Immunodeficiency (SCID) in the USA.